)
NAPIGEN
)
NAPIGEN is an American Biotech company with technology to enable editing of mitochondrial DNA, a decades-long previously unrealized agricultural goal. This creates unique opportunities to increase grain production by facilitating hybrid rice and wheat seed production, and by eliminating the need for nitrogen fertilizers, alleviating costs to farmers and the environment. We are raising $7 million for the second tranche of Series A to complete field testing of our enabling male-sterility plants for hybrid seed production and to obtain partnerships with AG companies.
HQ: Wilmington, Delaware, U.S.A.
Year founded: 2016
Employees: 16
Raised so far: $16M
Backed by: Grantham Foundation, RA Capital, ThriveSVG, etc.
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)